These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 24551202)

  • 1. GLA-AF, an emulsion-free vaccine adjuvant for pandemic influenza.
    Clegg CH; Roque R; Perrone LA; Rininger JA; Bowen R; Reed SG
    PLoS One; 2014; 9(2):e88979. PubMed ID: 24551202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant H5 hemagglutinin adjuvanted with nanoemulsion protects ferrets against pathogenic avian influenza virus challenge.
    Wang SH; Smith D; Cao Z; Chen J; Acosta H; Chichester JA; Yusibov V; Streatfield SJ; Fattom A; Baker JR
    Vaccine; 2019 Mar; 37(12):1591-1600. PubMed ID: 30795941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A nanoemulsion-adjuvanted intranasal H5N1 influenza vaccine protects ferrets against homologous and heterologous H5N1 lethal challenge.
    Smith D; Streatfield SJ; Acosta H; Ganesan S; Fattom A
    Vaccine; 2019 Sep; 37(42):6162-6170. PubMed ID: 31495593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adjuvant solution for pandemic influenza vaccine production.
    Clegg CH; Roque R; Van Hoeven N; Perrone L; Baldwin SL; Rininger JA; Bowen RA; Reed SG
    Proc Natl Acad Sci U S A; 2012 Oct; 109(43):17585-90. PubMed ID: 23045649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The adjuvant GLA-AF enhances human intradermal vaccine responses.
    Carter D; van Hoeven N; Baldwin S; Levin Y; Kochba E; Magill A; Charland N; Landry N; Nu K; Frevol A; Ashman J; Sagawa ZK; Beckmann AM; Reed SG
    Sci Adv; 2018 Sep; 4(9):eaas9930. PubMed ID: 30221194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Technology transfer of oil-in-water emulsion adjuvant manufacturing for pandemic influenza vaccine production in Romania: Preclinical evaluation of split virion inactivated H5N1 vaccine with adjuvant.
    Stavaru C; Onu A; Lupulescu E; Tucureanu C; Rasid O; Vlase E; Coman C; Caras I; Ghiorghisor A; Berbecila L; Tofan V; Bowen RA; Marlenee N; Hartwig A; Bielefeldt-Ohmann H; Baldwin SL; Van Hoeven N; Vedvick TS; Huynh C; O'Hara MK; Noah DL; Fox CB
    Hum Vaccin Immunother; 2016 Apr; 12(4):1009-26. PubMed ID: 26618392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A VLP vaccine induces broad-spectrum cross-protective antibody immunity against H5N1 and H1N1 subtypes of influenza A virus.
    Wu CY; Yeh YC; Chan JT; Yang YC; Yang JR; Liu MT; Wu HS; Hsiao PW
    PLoS One; 2012; 7(8):e42363. PubMed ID: 22879951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. M2SR, a novel live influenza vaccine, protects mice and ferrets against highly pathogenic avian influenza.
    Hatta Y; Boltz D; Sarawar S; Kawaoka Y; Neumann G; Bilsel P
    Vaccine; 2017 Jul; 35(33):4177-4183. PubMed ID: 28668565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthetic Toll-Like Receptor 4 (TLR4) and TLR7 Ligands Work Additively via MyD88 To Induce Protective Antiviral Immunity in Mice.
    Goff PH; Hayashi T; He W; Yao S; Cottam HB; Tan GS; Crain B; Krammer F; Messer K; Pu M; Carson DA; Palese P; Corr M
    J Virol; 2017 Oct; 91(19):. PubMed ID: 28724768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A cationic liposome-DNA complexes adjuvant (JVRS-100) enhances the immunogenicity and cross-protective efficacy of pre-pandemic influenza A (H5N1) vaccine in ferrets.
    Liu F; Sun X; Fairman J; Lewis DB; Katz JM; Levine M; Tumpey TM; Lu X
    Virology; 2016 May; 492():197-203. PubMed ID: 26967975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stockpiled pre-pandemic H5N1 influenza virus vaccines with AS03 adjuvant provide cross-protection from H5N2 clade 2.3.4.4 virus challenge in ferrets.
    Sun X; Belser JA; Pulit-Penaloza JA; Creager HM; Guo Z; Jefferson SN; Liu F; York IA; Stevens J; Maines TR; Jernigan DB; Katz JM; Levine MZ; Tumpey TM
    Virology; 2017 Aug; 508():164-169. PubMed ID: 28554058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuraminidase-Inhibiting Antibody Titers Correlate with Protection from Heterologous Influenza Virus Strains of the Same Neuraminidase Subtype.
    Walz L; Kays SK; Zimmer G; von Messling V
    J Virol; 2018 Sep; 92(17):. PubMed ID: 29925654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adjuvanted pandemic influenza vaccine: variation of emulsion components affects stability, antigen structure, and vaccine efficacy.
    Fox CB; Barnes V L; Evers T; Chesko JD; Vedvick TS; Coler RN; Reed SG; Baldwin SL
    Influenza Other Respir Viruses; 2013 Sep; 7(5):815-26. PubMed ID: 23122325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of safety and immunogenicity of recombinant influenza hemagglutinin (H5/Indonesia/05/2005) formulated with and without a stable oil-in-water emulsion containing glucopyranosyl-lipid A (SE+GLA) adjuvant.
    Treanor JJ; Essink B; Hull S; Reed S; Izikson R; Patriarca P; Goldenthal KL; Kohberger R; Dunkle LM
    Vaccine; 2013 Nov; 31(48):5760-5. PubMed ID: 24075920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved Immune Responses in Young and Aged Mice with Adjuvanted Vaccines against H1N1 Influenza Infection.
    Baldwin SL; Hsu FC; Van Hoeven N; Gage E; Granger B; Guderian JA; Larsen SE; Lorenzo EC; Haynes L; Reed SG; Coler RN
    Front Immunol; 2018; 9():295. PubMed ID: 29515589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The immune correlates of protection for an avian influenza H5N1 vaccine in the ferret model using oil-in-water adjuvants.
    Wong SS; Duan S; DeBeauchamp J; Zanin M; Kercher L; Sonnberg S; Fabrizio T; Jeevan T; Crumpton JC; Oshansky C; Sun Y; Tang L; Thomas P; Webby R
    Sci Rep; 2017 Mar; 7():44727. PubMed ID: 28303960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Flagellin-HA vaccines protect ferrets and mice against H5N1 highly pathogenic avian influenza virus (HPAIV) infections.
    Liu G; Song L; Reiserova L; Trivedi U; Li H; Liu X; Noah D; Hou F; Weaver B; Tussey L
    Vaccine; 2012 Nov; 30(48):6833-8. PubMed ID: 23000130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccines with MF59 adjuvant expand the antibody repertoire to target protective sites of pandemic avian H5N1 influenza virus.
    Khurana S; Chearwae W; Castellino F; Manischewitz J; King LR; Honorkiewicz A; Rock MT; Edwards KM; Del Giudice G; Rappuoli R; Golding H
    Sci Transl Med; 2010 Jan; 2(15):15ra5. PubMed ID: 20371470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single- and multiple-clade influenza A H5N1 vaccines induce cross protection in ferrets.
    Forrest HL; Khalenkov AM; Govorkova EA; Kim JK; Del Giudice G; Webster RG
    Vaccine; 2009 Jun; 27(31):4187-95. PubMed ID: 19406182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Broadened immunity and protective responses with emulsion-adjuvanted H5 COBRA-VLP vaccines.
    Allen JD; Owino SO; Carter DM; Crevar CJ; Reese VA; Fox CB; Coler RN; Reed SG; Baldwin SL; Ross TM
    Vaccine; 2017 Sep; 35(38):5209-5216. PubMed ID: 28789850
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.